- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18.06. | Cellular Origins, Thermo Fischer Scientific Partner to Manufacture Industrial CGTs | ||
| 18.06. | Mabion Launches €500,000 Oncology Services Contest | ||
| 18.06. | Fareva Pilots New GMP Unit at Its Pau Site | ||
| 17.06. | Lifecore Biomedical Enters 10-Year Commercial Manufacturing & Supply Agreement with Existing Customer | ||
| 16.06. | Teva, Fosun Pharma Partner to Develop Immuno-Oncology Therapy | ||
| 16.06. | Anne Wojcicki's Nonprofit Tops Bid for 23andMe Assets | ||
| 16.06. | Ecolab Life Sciences Introduces New Resin | ||
| 13.06. | AstraZeneca, CSPC Pharmaceuticals Partner for Novel Oral Therapies | ||
| 13.06. | FDA Approves Keytruda for PD-L1+ as Neoadjuvant Treatment | ||
| 13.06. | MRI & Astellas Fuel Japan's Drug Discovery Hub | ||
| 12.06. | TekniPlex Commences Production at New Facility in Madison, Wisconsin | ||
| 12.06. | Debiopharm, Alkyon Therapeutics to Research Radioligand Therapies | ||
| 12.06. | BioNTech Agrees to Acquire All Shares of CureVac | ||
| 12.06. | U.S. FDA Approves Nuvation Bio's Ibtrozi | ||
| 12.06. | Cryoport Completes Divesture of CRYOPDP | ||
| 11.06. | PL BioScience Taps Oliver Dick as Chief Technology Officer | ||
| 11.06. | MaxCyte & Ori Biotech Integrate Platforms for Efficient Manufacturing | ||
| 11.06. | Schreiner MediPharm Introduces Smart Syringe Box | ||
| 11.06. | Philochem Licenses OncoACP3 Worldwide Rights to RayzeBio | ||
| 11.06. | Great Point Partners Acquires Majority Stake in Eutecma | ||
| 11.06. | Simtra BioPharma Solutions & MilliporeSigma Enter Strategic Alliance | ||
| 11.06. | Novo Nordisk Signs $800M+ Deal with Deep Apple Therapeutics for Obesity R&D | ||
| 10.06. | Echosens & Boehringer Ingelheim Expand Long-Standing Collaboration | ||
| 10.06. | Sanyou Biopharma, Medicovestor Partner on Chemoimmunotherapy ADCs | ||
| 10.06. | BioDuro & Silicogenix Accelerates Novel Drug Discovery for Complex Diseases |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .